3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Leukemia, Myeloid, Chronic-Phase
7
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Philadelphia Chromosome
2
Pancreatic Neoplasms
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Glioma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Interventions
fludarabine
7
Whole-Body Irradiation
6
Cyclophosphamide
6
venetoclax
5
fludarabine phosphate
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Busulfan
4
asciminib
3
gilteritinib
2
blinatumomab
2
aldesleukin
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Interleukin-2
2
Idarubicin
2
Cytarabine
2
Bone Marrow Transplantation
2
Azacitidine
2
ponatinib
1
nilotinib
1
nicotinamide-beta-riboside
1
methanesulfonic acid
1
enasidenib
1
Thiotepa
1
Stem Cell Transplantation
1
Social Determinants of Health
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Dasatinib
×
1 year
×
Clear all
No trials found.